title: Resolution of renal allograft-associated post-transplant lymphoproliferative disorder with the introduction of sirolimus.
authors.affiliation: Renal Transplantation, St Michael's Hospital, University of Toronto, 30 Bond St, Toronto, Ontarion, Canada M5B1W8. jeffrey.zaltzman@utoronto.ca
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Zaltzman
authors.forename: Ramesh
authors.initials: R
authors.lastname: Prasad
authors.forename: Kathy
authors.initials: K
authors.lastname: Chun
authors.forename: Serge
authors.initials: S
authors.lastname: Jothy
mesh_terms: D000328:Adult; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D011183:Postoperative Complications; D020123:Sirolimus / Q000627:therapeutic use*; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus